Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

TRENDING TOPICS:

  • Medicaid Work Mandate
  • Suicide Prevention
  • Community Health Workers
  • Rural Health Payout
  • Opioid Crisis

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, May 28 2021

Full Issue

Persistent Symptoms Common For Covid Patients

Nearly three quarters of the people who recover from covid have persistent problems. The most common symptoms are shortness of breath and fatigue, according to a literature review published by JAMA. Another study says heart inflammation from covid is rare among athletes tested.

CIDRAP: Review Finds Persistent Symptoms In 73% Of COVID-19 Patients

Almost three quarters of patients reported at least one persisting COVID-19 symptom during follow-up, with the most common being shortness of breath and fatigue, according to a literature review published in JAMA Network Open yesterday. The researchers looked at 45 studies published from Jan 1, 2020, to Mar 11, 2021, and defined long-haul COVID as either 60 days after diagnosis, symptom onset, or hospitalization, or at least 30 days after acute illness recovery or hospital discharge. The largest proportion of studies came from China (7), followed by the United Kingdom (6), Spain (6), Italy (5), France (4), and the United States (3). (5/27)

AP: Heart Inflammation After Virus Is Rare In Big Ten Athletes

The results from the Big Ten COVID-19 Cardiac Registry show just 37 of nearly 1,600 athletes — a little over 2% — had evidence of heart inflammation on imaging tests. Of these, nine athletes had any chest pain, palpitations or other symptoms, according to the study published Thursday in JAMA Cardiology. Follow-up testing showed inflammation had disappeared a month later in most of the athletes affected, but about 40% of the 37 had scarring. The researchers said it is uncertain whether these affects pose a substantial health risk, although myocarditis, the medical term for the type of heart inflammation involved, is a leading cause of sudden death in athletes. (Tanner, 5/27)

In other research news —

CIDRAP: Big Spikes In Overdose Cardiac Arrests, Opioid Deaths Amid COVID-19

Two new JAMA studies reveal startling jumps in overdose-related cardiac arrests and fatal opioid overdoses during the COVID-19 pandemic. The first study, led by University of California, Los Angeles, researchers and published yesterday in JAMA Psychiatry, involved 33.4 million patient emergency medical services (EMS) encounters from the beginning of the pandemic to May 2020 in the US National EMS Information System, a database of EMS visits from more than 11,000 agencies in 49 states. These visits made up more than 87% of all EMS encounters in 2020. (Van Beusekom, 5/27)

Stat: Inequities In Cancer Genomics Undercut Precision Medicine

Translating the promise of cancer genomics into health equity has not yet become a reality, two experts write in a commentary published recently in Cancer Cell. Instead, the racial gaps in cancer mortality have only slightly narrowed since the human genome was sequenced two decades ago, they note, and in preventable cancers such as breast and colorectal cancer, socioeconomic inequalities in cancer deaths are widening. (Cooney, 5/28)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Wednesday, April 29
  • Tuesday, April 28
  • Monday, April 27
  • Friday, April 24
  • Thursday, April 23
  • Wednesday, April 22
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF